Eosinophil extracellular traps in a patient with chronic eosinophilic pneumonia.
Bronchoalveolar lavage fluid
ETosis
Eosinophils
Extracellular traps
Pulmonary eosinophilia
Journal
Asia Pacific allergy
ISSN: 2233-8276
Titre abrégé: Asia Pac Allergy
Pays: Netherlands
ID NLM: 101561954
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
20
01
2021
accepted:
06
07
2021
entrez:
13
8
2021
pubmed:
14
8
2021
medline:
14
8
2021
Statut:
epublish
Résumé
Eosinophils rapidly release extracellular filamentous chromatin fibers (extracellular traps, ETs) when they are stimulated. Reticulated ETs have been recently shown to affect secretion viscosity in eosinophilic inflammatory diseases. Here we report a 43-year-old woman with infiltrative shadows in both upper lungs that did not respond well to antibiotics. She admitted to occasional coughing and sputum, but had poor viscous regulation. Bronchoalveolar lavage fluid (BALF) collected from the upper left lobe showed many eosinophils (65%). She was diagnosed with chronic eosinophilic pneumonia, per previously reported criteria, and began treatment with prednisolone. The infiltration shadow gradually improved, and she was discharged 28 days after admission. Later, we immune-stained her BALF cell components with antibodies against major basic protein, an eosinophil granule protein, which showed a large number of agglomerating eosinophils; and antibodies against citrullinated histone H3 (CitH3-a marker for ETs), which showed CitH3-positive ETs, spread in a network. These findings confirmed that some BALF eosinophils released eosinophil ETs. This case shows the existence of ETs from BALF in patients with chronic eosinophilic pneumonia. Concentration of eosinophil ETs in eosinophilic inflammatory diseases may affect secretion viscosity in sputum, and so on.
Identifiants
pubmed: 34386400
doi: 10.5415/apallergy.2021.11.e24
pmc: PMC8331252
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e24Informations de copyright
Copyright © 2021. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.
Déclaration de conflit d'intérêts
Conflict of Interest: SU received honoraria for lectures from AstraZeneca; and has received grant support from AstraZeneca and Maruho Co. Ltd. The other authors declare no competing financial interests.
Références
J Allergy Clin Immunol. 2018 Feb;141(2):571-585.e7
pubmed: 28943470
Asia Pac Allergy. 2020 Jul 08;10(3):e24
pubmed: 32789109
Asia Pac Allergy. 2018 Jul 16;8(3):e24
pubmed: 30079302
Medicine (Baltimore). 1998 Sep;77(5):299-312
pubmed: 9772920
Auris Nasus Larynx. 2011 Aug;38(4):456-61
pubmed: 21251776
Ther Clin Risk Manag. 2019 Mar 13;15:397-403
pubmed: 30936702
J Int Med Res. 1997 Jul-Aug;25(4):196-201
pubmed: 9283992
J Allergy Clin Immunol. 2016 Jan;137(1):258-267
pubmed: 26070883
J Innate Immun. 2018;10(5-6):414-421
pubmed: 29909412
Curr Allergy Asthma Rep. 2016 Jul;16(8):54
pubmed: 27393701
Oral Dis. 2020 Oct;26(7):1459-1463
pubmed: 32436360
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Front Immunol. 2016 Aug 15;7:311
pubmed: 27574522
Allergol Int. 2019 Oct;68(4):413-419
pubmed: 31253537
Laryngoscope. 2000 May;110(5 Pt 1):799-813
pubmed: 10807359
Blood. 2013 Mar 14;121(11):2074-83
pubmed: 23303825
Front Immunol. 2018 Oct 11;9:2346
pubmed: 30364279